[1]
A. F. Abdulaziz alsalem, “Evaluating the Risk of Type 2 Diabetes Mellitus Using Artificial Neural Network”, International Journal of Pharmaceutical and Bio Medical Science, vol. 2, no. 11, pp. 546–551, Nov. 2022.